Skip to main content
. 2016 May 15;7(25):38010–38024. doi: 10.18632/oncotarget.9380

Figure 9. A summary of signaling pathways affected by CAPE treatment in PC-3 and DU-145 cells.

Figure 9

Red arrows indicate signaling proteins being elevated by CAPE treatment, while blue arrows indicate signaling being suppressed by CAPE treatment.

HHS Vulnerability Disclosure